BCAB

Bioatla, Inc.

4.870

-0.290-5.62%

After Hours: 4.870 0.000 0.00%16:10 04/24 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE4.135/4.270

TODAY RANGE4.135-4.135

VOL565

MARKET CAP6.85M

52 WEEK RANGE3.920-71.50

AVG VOL (3M)43.08K

% TURNOVER0.03%

TURNOVER--

P/E (TTM)-0.0816

% RANGE0.00%

EPS(TTM)-50.6621

P/E(FORWARD)-0.0766

P/B-0.1450

BVPS-28.5112

DIVIDEND--

P/S2.624

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP6.42M

SHARES OUTSTANDING1.66M

NEXT EARNINGS05/04-05/08

FREE FLOAT1.55M

LOT SIZE1

EX-DATE04/06/2026

News

Press Releases

Financial Reports

Profile

TipRanks·04/07 12:45
Why Is Vanguard Total Stock Market ETF (VTI) Falling Today, 4/7/2026?
TipRanks·04/06 13:08
Why Is Vanguard Total Stock Market ETF (VTI) Up Today, 4/6/2026?
TipRanks·04/05 15:28
Upcoming Stock Splits This Week (April 6-10, 2026) – Stay Invested
TipRanks·04/03 13:27
Vanguard Total Stock Market ETF (VTI) Daily Update, 4/3/26?
TipRanks·04/02 23:50
BioAtla trading halted, news pending
TipRanks·04/02 21:00
BioAtla Announces 1-for-50 Reverse Stock Split Merger
Reuters·04/02 20:09
BioAtla completes merger of BA Merger Sub into company effective April 6, 2026
TipRanks·04/02 12:14
Why Is Vanguard Total Stock Market ETF (VTI) Down Today, 4/2/26?
TipRanks·04/01 13:18
Vanguard Total Stock Market ETF (VTI) Daily Snapshot — 4/1/26
TipRanks·03/31 23:46
BioAtla Begins Strategic Review Following 2025 Results
TipRanks·03/31 20:45
BioAtla announces 50-for-1 share consolidation
Reuters·03/31 20:31
BioAtla Q4 net loss narrows on lower expenses
Seeking Alpha·03/31 20:12
BioAtla to implement 50-for-1 share consolidation
Reuters·03/31 20:10
BioAtla to execute 50-for-1 share consolidation April 6
Dow Jones·03/31 20:09
*BioAtla: Re-evaluating the Timing and Scope of Clinical Development Programs >BCAB

Same Industry

Name/Symbol

Change%

Price

Bioatla, Inc.

BCAB

-5.62%

4.870

Regeneron Pharmaceuticals

REGN

-0.95%

744.44

GridAI Tech

GRDX

-1.79%

2.200

BIONTECH

BNTX

-5.71%

97.54

United Therapeutics Corp.

UTHR

-0.17%

570.40

Vertex Pharmaceuticals Inc

VRTX

-0.81%

423.92

SIGA

Moderna

MRNA

-3.28%

49.07

CRL

Medpace Holdings

MEDP

+4.35%

410.54

Talphera Inc

TLPH

+3.46%

0.7646

ICON PLC

ICLR

-3.92%

102.17

China Biologic

CBPO

0.00%

119.99

Iqvia Hldgs Inc

IQV

-2.97%

158.98

MOLECULAR PARTNERS AG

MOLN

-2.46%

4.350

Arcturus Therape

ARCT

+1.42%

8.59

Gilead Sciences Inc

GILD

-2.42%

130.40

PRA Health

PRAH

0.00%

165.21

Incyte Corp

INCY

+2.12%

97.74

Aptevo Therapeutics Inc

APVO

-0.30%

4.905

BSTC

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.